Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop

Journal Article · · Nature Communications

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
NIHNIAID
OSTI ID:
1476094
Journal Information:
Nature Communications, Vol. 9, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH

References (36)

Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability May 2017
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses May 2017
Synergistic drug combination effectively blocks Ebola virus infection January 2017
Overview of the CCP 4 suite and current developments March 2011
The LANL hemorrhagic fever virus database, a new platform for analyzing biothreat viruses November 2011
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site May 2016
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection June 2013
Structures of protective antibodies reveal sites of vulnerability on Ebola virus November 2014
Coot model-building tools for molecular graphics November 2004
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection June 2016
Toremifene interacts with and destabilizes the Ebola virus glycoprotein June 2016
Possible FDA-approved drugs to treat Ebola virus infection May 2015
Viral membrane fusion May 2015
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein October 2015
PHENIX: a comprehensive Python-based system for macromolecular structure solution January 2010
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies August 2016
A shared structural solution for neutralizing ebolaviruses November 2011
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1 January 2016
PHENIX : building new software for automated crystallographic structure determination October 2002
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody May 2016
The Primed Ebolavirus Glycoprotein (19-Kilodalton GP1,2): Sequence and Residues Critical for Host Cell Binding January 2009
Virus Variation Resource – improved response to emergent viral outbreaks November 2016
Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity September 2017
Human Adaptation of Ebola Virus during the West African Outbreak November 2016
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic November 2016
Ebolavirus Entry Requires a Compact Hydrophobic Fist at the Tip of the Fusion Loop April 2014
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor July 2008
XDS January 2010
Inference of Macromolecular Assemblies from Crystalline State September 2007
Structural and molecular basis for Ebola virus neutralization by protective human antibodies February 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability November 2016
WebLogo: A Sequence Logo Generator May 2004
Crystal Structure of the Ebola Virus Membrane Fusion Subunit, GP2, from the Envelope Glycoprotein Ectodomain November 1998
Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity January 2010
Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection January 2018
Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model June 2017